DE69118565T2 - Thiazolidinderivate mit antidiabetischer Wirkung, ihre Herstellung und Anwendung - Google Patents

Thiazolidinderivate mit antidiabetischer Wirkung, ihre Herstellung und Anwendung

Info

Publication number
DE69118565T2
DE69118565T2 DE69118565T DE69118565T DE69118565T2 DE 69118565 T2 DE69118565 T2 DE 69118565T2 DE 69118565 T DE69118565 T DE 69118565T DE 69118565 T DE69118565 T DE 69118565T DE 69118565 T2 DE69118565 T2 DE 69118565T2
Authority
DE
Germany
Prior art keywords
preparation
thiazolidine derivatives
hydrogen
diabetic effect
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69118565T
Other languages
English (en)
Other versions
DE69118565D1 (de
Inventor
Takao Yoshioka
Takashi Fujita
Tsutomu Kanai
Kanichi Nakamura
Hiroyoshi Hirikoshi
Kunihiro Sasahara
Takeshi Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69118565D1 publication Critical patent/DE69118565D1/de
Publication of DE69118565T2 publication Critical patent/DE69118565T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69118565T 1990-02-07 1991-02-06 Thiazolidinderivate mit antidiabetischer Wirkung, ihre Herstellung und Anwendung Expired - Fee Related DE69118565T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2802390 1990-02-07

Publications (2)

Publication Number Publication Date
DE69118565D1 DE69118565D1 (de) 1996-05-15
DE69118565T2 true DE69118565T2 (de) 1997-01-09

Family

ID=12237153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118565T Expired - Fee Related DE69118565T2 (de) 1990-02-07 1991-02-06 Thiazolidinderivate mit antidiabetischer Wirkung, ihre Herstellung und Anwendung

Country Status (12)

Country Link
US (1) US5143930A (de)
EP (1) EP0441605B1 (de)
KR (1) KR0184601B1 (de)
AT (1) ATE136544T1 (de)
AU (1) AU637456B2 (de)
CA (1) CA2035832C (de)
DE (1) DE69118565T2 (de)
DK (1) DK0441605T3 (de)
ES (1) ES2088459T3 (de)
FI (1) FI910583A (de)
GR (1) GR3020196T3 (de)
HK (1) HK1005451A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93138T1 (de) * 1990-02-09 1993-09-15 Upjohn Co Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
NO302471B1 (no) * 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
ES2139633T3 (es) 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
JP3195455B2 (ja) * 1993-01-06 2001-08-06 ウェルファイド株式会社 キノリン−3−酢酸誘導体、その製造法と用途
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
CA2159938A1 (en) * 1994-10-07 1996-04-08 Hiroaki Yanagisawa Oxime derivatives, their preparation and their therapeutic use
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
EP1022272B1 (de) 1997-10-08 2004-05-26 Sankyo Company Limited Substituierte kondensierte heterocyclische verbindungen
US6946295B2 (en) * 1998-06-12 2005-09-20 Cellfor, Inc. Process for ex vitro sowing and germination of plant somatic embryos
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
JP2004516279A (ja) * 2000-12-18 2004-06-03 スミスクライン・ビーチャム・コーポレイション チアゾリジンジオン類
CA2783468C (en) 2009-12-15 2018-10-09 Metabolic Solutions Development Company, Llc Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
HUE030263T2 (en) 2010-04-19 2017-04-28 Octeta Therapeutics Llc New synthesis for the preparation of thiazolidinedione compounds
PL2603498T3 (pl) 2010-08-10 2017-06-30 Octeta Therapeutics, Llc Nowa synteza związków tiazolidynodionu
KR101857307B1 (ko) * 2010-08-10 2018-05-11 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 티아졸리딘디온 화합물의 합성법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US4933355A (en) * 1988-04-14 1990-06-12 Sankyo Company Limited Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
EP0441605A2 (de) 1991-08-14
EP0441605A3 (en) 1992-01-22
AU637456B2 (en) 1993-05-27
DK0441605T3 (da) 1996-07-29
FI910583A (fi) 1991-08-08
CA2035832C (en) 2000-08-29
KR0184601B1 (ko) 1999-05-01
EP0441605B1 (de) 1996-04-10
GR3020196T3 (en) 1996-09-30
US5143930A (en) 1992-09-01
FI910583A0 (fi) 1991-02-07
HK1005451A1 (en) 1999-01-08
CA2035832A1 (en) 1991-08-08
AU7090691A (en) 1991-08-08
DE69118565D1 (de) 1996-05-15
ES2088459T3 (es) 1996-08-16
ATE136544T1 (de) 1996-04-15
KR910015552A (ko) 1991-09-30

Similar Documents

Publication Publication Date Title
DE69118565T2 (de) Thiazolidinderivate mit antidiabetischer Wirkung, ihre Herstellung und Anwendung
NO905572L (no) Fremgangsmaate for fremstilling av peptidforbindelser.
KR890000485A (ko) 캠프토데신 유도체 및 그의 아미노기에 있어서의 산 부가염 및 4급 암모늄염 및 그의 제조방법
WO1998035951A3 (en) New aminopiperazine derivatives
DE69222459T2 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
DE69204041T2 (de) Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung.
SE8406141L (sv) N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa
FI931346A (fi) Butadienderivat och foerfarande foer deras framstaellning
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
IE872234L (en) Derivatives of indane
HUT57833A (en) Process for producing new macrolide compounds and pharmaceutical compositions comprising same as active ingredient
IE862707L (en) Dichloroaniline derivatives
ATE236162T1 (de) Pyrroloazepinderivate
IE890259L (en) Macrolide compounds
DE3873170T2 (de) Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.
FI20021652A (fi) Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita
ATE112682T1 (de) Isocarbacyclinderivate enthaltende antidiabetika.
SE8703068L (sv) Komposition for att inducera och stimulera hartillvext och minska haravfall baserad pa pyrimidinderivat
ATE129246T1 (de) Pyrazolo(1,5-a)pyridine, deren herstellung und verwendung.
FI841207A (fi) Troponderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk komposition.
SE9201188L (sv) Ny användning
FI841611A0 (fi) 1,3-bis(dimetylamino)-2-propyl-4- klorofenoxiacetat, foerfarande foer framstaellning av detta och denna foeren foerening innehaollande laekemedelspreparat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee